Welcome to COMPPARE
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer. Patient enrollment in COMPPARE closed October 31, 2022.
Visit Our newsROOM
The Importance of the Primary Completion Date
When you volunteered for COMPPARE, you might have heard about something its PCD. But what does that mean for you, really?
Why Your Participation in COMPPARE Matters More…
Our most critical insights will come years after treatment ends, as long-term follow-up is essential to understanding lasting effects and benefits.
COMPPARE Publishes Latest Newsletter
Learn about the importance of the Primary Completion Date, an exciting alternative to MRIs for prostate cancer biopsies, and more.
For participants
For Healthcare providers
Consortium Materials
Study-specific materials and other information.
ClinicalTrials.gov
Privately and publicly funded clinical studies conducted around the world.